Archivos de Bronconeumología
ISSN: 0300-2896

Archivos de Bronconeumologia is a scientific journal that preferentially publishes prospective original research articles whose content is based upon results dealing with several aspects of respiratory diseases such as epidemiology, pathophysiology, clinics, surgery, and basic investigation. Other types of articles such as reviews, editorials, a few special articles of interest to the society and the editorial board, scientific letters, letters to the Editor, and clinical images are also published in the Journal. It is a monthly Journal that publishes a total of 12 issues and a few supplements, which contain articles belonging to the different sections.

All the manuscripts received in the Journal are evaluated by the Editors and sent to expert peer-review while handled by the Editor and/or an Associate Editor from the team. The Journal is published monthly in English.

Manuscripts will be submitted electronically using the following web site:, link which is also accessible through the main web page of Archivos de Bronconeumologia.

Access to any published article, is possible through the Journal's web page as well as from PubMed, Science Direct, and other international databases. Furthermore, the Journal is also present in Twitter and Facebook. The Journal expresses the voice of the Spanish Respiratory Society of Pulmonology and Thoracic Surgery (SEPAR) as well as that of other scientific societies such as the Latin American Thoracic Society (ALAT) and the Iberian American Association of Thoracic Surgery (AICT).

Authors are also welcome to submit their articles to the Journal's open access companion title, Open Respiratory Archives.

See more
Archivos de Bronconeumologia has received the new Impact Factor (JCR). The impact factor has risen from 6.333 in 2021 to 8 in the last evaluated year, 2022.
It is needed to be a member of SEPAR or have a subscription to access full texts of articles published last year. Abstracts are available for all visitors.

Indexed in:

Current Contents/Clinical Medicine, JCR SCI-Expanded, Index Medicus/Medline, Excerpta Medica/EMBASE, IBECS, IME, SCOPUS, IBECS

See more

Follow us:


Impact factor

The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years.

© Clarivate Analytics, Journal Citation Reports 2022

See more
Impact factor 2022

CiteScore measures average citations received per document published.

See more
Citescore 2022

SRJ is a prestige metric based on the idea that not all citations are the same. SJR uses a similar algorithm as the Google page rank; it provides a quantitative and qualitative measure of the journal's impact.

See more
SJR 2022

SNIP measures contextual citation impact by wighting citations based on the total number of citations in a subject field.

See more
SNIP 2022
View more metrics
Vol. 60. Issue 5.
Pages 261-326 (May 2024)
Arch Bronconeumol. 2024;60:CO1
Editorial Board
Arch Bronconeumol. 2024;60:i
Arch Bronconeumol. 2024;60:iii-iv
Unraveling the Enigma: Spain Takes a Pioneering Step With REPAIR in the World of Inhaled Antibiotics
David de la Rosa-Carrillo, Marc Miravitlles, Xavier Pomares, Miguel-Ángel Martínez-García
Arch Bronconeumol. 2024;60:261-2
Potential Benefits of a Cardiovascular Polypill in Long COVID Patients
Joan B. Soriano
Arch Bronconeumol. 2024;60:263-4
Challenges for Scientific Societies: New Tobacco-Derived Products
Jaime Signes-Costa, Carlos Rábade-Castedo, Carlos A. Jiménez-Ruiz
Arch Bronconeumol. 2024;60:265-6
Inspiratory Muscle Training: Back to Basics Must be the First Step?
Gonzalo Ballesteros-Reviriego, Ane Arbillaga-Etxarri, Joan-Daniel Martí
Arch Bronconeumol. 2024;60:267-8
Original articles
N-acetylcysteine Treatment in Chronic Obstructive Pulmonary Disease (COPD) and Chronic Bronchitis/Pre-COPD: Distinct Meta-analyses
Alberto Papi, Franco Alfano, Tommaso Bigoni, Lorenzo Mancini, Amal Mawass, Federico Baraldi, Cristina Aljama, Marco Contoli, Marc Miravitlles
Arch Bronconeumol. 2024;60:269-78

  • Treatment effects on PROs in chronic bronchitis (CB) with/out COPD are scarcely known.

  • N-acetylcysteine (NAC) improve symptoms and/or QoL in studies conducted in CB.

  • NAC reduce exacerbations in studies conducted in subjects with CB.

  • Similarly, NAC reduce exacerbations and improve symptoms and/or QoL in COPD studies.

Adaptation and Validation of the Hooked on Nicotine Checklist (HONC) with Spanish Adolescents
Nuria García-Couceiro, Sion Kim-Harris, Patricia Gómez, Manuel Isorna, Antonio Rial
Arch Bronconeumol. 2024;60:279-84
Separ's voice
Multidisciplinary Consensus on the Management of Non-Invasive Respiratory Support in the COVID-19 Patient
Manel Luján, César Cinesi Gómez, Oscar Peñuelas, Carlos Ferrando, Sarah Béatrice Heili-Frades, José Manuel Carratalá Perales, Arantxa Mas, Javier Sayas Catalán, ... Carlos Egea Santaolalla
Arch Bronconeumol. 2024;60:285-95
Case reports
Benefits of Inspiratory Muscle Training in Myotonic Dystrophy: A Case Report
Charlotte G.W. Seijger, Jellie Nieuwenhuis, Baziel G.M. van Engelen, Peter J. Wijkstra
Arch Bronconeumol. 2024;60:296-7
Granulomatosis With Polyangiitis as a Trigger for Acute Myeloid Leukemia
Ignacio Boira Enrique, Violeta Esteban Ronda, Eusebi Chiner Vives
Arch Bronconeumol. 2024;60:300-1
Clinical images
Thoracic Amyloidosis – A Respiratory Conundrum
Mohamed Tofeig, Gregory Cross, Monika Radike
Arch Bronconeumol. 2024;60:302-3
Delayed Presentation of Traumatic Diaphragmatic Rupture With Hemothorax
Ayla Buyukkaya, Ramazan Buyukkaya
Arch Bronconeumol. 2024;60:304-5
Endobronchial High-Grade Non-Hodgkin B-Cell Lymphoma Mimicking Small Cell Lung Cancer
Luca Sardella, Elisabetta Merlo, Alessio Casutt
Arch Bronconeumol. 2024;60:306-7
Cheerio Sign: Pulmonary Langerhans Cell Histiocytosis
Alejandro García García, Jorge Mora Pinilla, Beatriz Raboso Moreno, María Teresa Río Ramírez, Araceli Abad Fernández
Arch Bronconeumol. 2024;60:308-9
Bronchoscopic Diagnosis of Hematogenous Recurrence of Thymoma
Miki Tasato, Akihiko Sokai, Takashi Nishimura
Arch Bronconeumol. 2024;60:310-1
Scientific letters
Analysis of the Evolution of Tuberculosis in Men and Women in Spain Between 2017 and 2022. Is There a Different Incidence Decline by Gender?
Teresa Rodrigo, Eva M.a Tabernero, Luis Anibarro, José A. Gullón, Juan F. Medina, Joan P. Millet, Marta M.a García-Clemente, Antonia Sáez, ... Integrated Tuberculosis, Non-Tuberculous Mycobacteria Research Programme Working Group PII-TB MNT of SEPAR
Arch Bronconeumol. 2024;60:312-5
Everyone was Fooled, it Burns: Simple Diy Proof of the Falsity of Heat-Not-Burn Tobacco
Alejandro Frino-García, Eli Nancy Pérez Rodas, Fernanda Hernández-González, Xavier Alsina-Restoy, Pamela Kette-Aguilera, Carlos Jiménez Ruiz, Carlos Rabade Castedo, José Ignacio De Granda-Orive, ... Jacobo Sellares
Arch Bronconeumol. 2024;60:316-8
What to Do When Endobronchial Volume Reduction Treatment Fails
Selene Cuenca Peris, Raquel Martínez Tomás, Andrés Briones Gómez, Enrique Cases Viedma
Arch Bronconeumol. 2024;60:319-20
Risk Stratification in Pulmonary Veno-Occlusive Disease
Alejandro Cruz-Utrilla, Carmen Pérez-Olivares, Raquel Luna-López, Carmen Jiménez López-Guarch, Pedro Bedate, Amaya Martínez Meñaca, Manuel López Meseguer, Pilar Escribano-Subias
Arch Bronconeumol. 2024;60:321-3
Letter to the director
Effective IMT Starts With a Feasible Training Protocol and Identification of Clinical Relevant Outcome Parameters
Charlotte G.W. Seijger, Jellie Nieuwenhuis, Baziel G.M. van Engelen, Peter J. Wijkstra
Arch Bronconeumol. 2024;60:326
Archivos de Bronconeumología

Are you a health professional able to prescribe or dispense drugs?